When taken as an injectable medication, semaglutide stimulates the release of GLP-1 and suppresses appetite, resulting in fewer calories consumed and a decrease in body weight
Rybelsus was the first oral GLP-1 approved for diabetes, available in 3mg, 7mg, and 14mg daily tablets
Managing low blood pressure while taking semaglutide involves a combination of lifestyle changes and medical interventions
KDM4C-mediated senescence defense is a targetable vulnerability in gastric cancer harboring TP53 mutations
Subjects randomized to the 1.0 mg semaglutide treatment arm would escalate to the 1.0 mg dose after 4 weeks of 0.5 mg semaglutide, remaining on this dose for the duration of the trial
Combined with copper ions, another study explored the antimicrobial and wound healing potential of glutathione against multidrug-resistant (MDR) bacterial infections, where it prevented postsurgical wound infections and aided in wound closure